As of June 28 at 6:07:38 PM EDT. Market Open.
Researchers from Nordic Nanovector ASA presented the discovery of a novel humanized anti-CD37 monoclonal antibody, NNV-024, engineered to exhibit a strong antibody-dependent cellular cytotoxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results